Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 1992; Volume 41,Issue 1
  • You have access
    The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor.
    N Adham, P Romanienko, P Hartig, R L Weinshank and T Branchek
    Molecular Pharmacology January 1992, 41 (1) 1-7;
  • You have access
    In vitro evidence for direct complexation of ADR-529/ICRF-187 [(+)-1,2-bis-(3,5-dioxo-piperazin-1-yl)propane] onto an existing ferric-anthracycline complex.
    M M Sobol, R G Amiet and M D Green
    Molecular Pharmacology January 1992, 41 (1) 8-17;
  • You have access
    Solubilization, purification, and functional reconstitution of 5-hydroxytryptamine3 receptors from N1E-115 neuroblastoma cells.
    S C Lummis and I L Martin
    Molecular Pharmacology January 1992, 41 (1) 18-23;
  • You have access
    Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor.
    T M Fong, S A Anderson, H Yu, R R Huang and C D Strader
    Molecular Pharmacology January 1992, 41 (1) 24-30;
  • You have access
    A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
    C M Flores, S W Rogers, L A Pabreza, B B Wolfe and K J Kellar
    Molecular Pharmacology January 1992, 41 (1) 31-37;
  • You have access
    2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl] methyl)hexanamide (NPC 15437): a novel inhibitor of protein kinase C interacting at the regulatory domain.
    J P Sullivan, J R Connor, B G Shearer and R M Burch
    Molecular Pharmacology January 1992, 41 (1) 38-44;
  • You have access
    Ion dependence of the partially purified mitochondrial dihydropyridine Ca2+ antagonist receptor.
    G Zernig and N Reider
    Molecular Pharmacology January 1992, 41 (1) 45-52;
  • You have access
    Stable expression, secretion, and characterization of active human renin in mammalian cells.
    J A Norman, O Hadjilambris, R Baska, D Y Sharp and R Kumar
    Molecular Pharmacology January 1992, 41 (1) 53-59;
  • You have access
    Activation of the transcription factor kappa B in human KG-1 myeloid leukemia cells treated with 1-beta-D-arabinofuranosylcytosine.
    M A Brach, S M Kharbanda, F Herrmann and D W Kufe
    Molecular Pharmacology January 1992, 41 (1) 60-63;
  • You have access
    Transcriptional and posttranscriptional regulation of H1 histone gene expression by 1-beta-D-arabinofuranosylcytosine.
    R Datta, S Kharbanda and D W Kufe
    Molecular Pharmacology January 1992, 41 (1) 64-68;
  • You have access
    Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
    C C Chao, Y T Huang, C M Ma, W Y Chou and S Lin-Chao
    Molecular Pharmacology January 1992, 41 (1) 69-75;
  • You have access
    Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human IIE1.
    S A Wrighton, M Vandenbranden, G W Becker, S D Black and P E Thomas
    Molecular Pharmacology January 1992, 41 (1) 76-82;
  • You have access
    The polyamine spermine has multiple actions on N-methyl-D-aspartate receptor single-channel currents in cultured cortical neurons.
    D M Rock and R L Macdonald
    Molecular Pharmacology January 1992, 41 (1) 83-88;
  • You have access
    Effects of steroids on gamma-aminobutyric acid receptors expressed in Xenopus oocytes by poly(A)+ RNA from mammalian brain and retina.
    R M Woodward, L Polenzani and R Miledi
    Molecular Pharmacology January 1992, 41 (1) 89-103;
  • You have access
    Antagonistic effect of a vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation.
    J F Goossens, N Pommery, M Lohez, J Pommery, N Helbecque, P Cotelle, M Lhermitte and J P Henichart
    Molecular Pharmacology January 1992, 41 (1) 104-109;
  • You have access
    Dynamic control of inositol 1,4,5-trisphosphate-induced Ca2+ release: a theoretical explanation for the quantal release of Ca2+.
    S Swillens
    Molecular Pharmacology January 1992, 41 (1) 110-114;
  • You have access
    Luminal Ca2+ increases the sensitivity of Ca2+ stores to inositol 1,4,5-trisphosphate.
    D L Nunn and C W Taylor
    Molecular Pharmacology January 1992, 41 (1) 115-119;
  • You have access
    Slow voltage-dependent block of sodium channels in crayfish nerve by dihydropyrazole insecticides.
    V L Salgado
    Molecular Pharmacology January 1992, 41 (1) 120-126;
  • You have access
    Effects of isoflurane on acetylcholine receptor channels. 1. Single-channel currents.
    J P Dilger, R S Brett and L A Lesko
    Molecular Pharmacology January 1992, 41 (1) 127-133;
  • You have access
    High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel.
    P H Franklin and T F Murray
    Molecular Pharmacology January 1992, 41 (1) 134-146;
  • You have access
    Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
    D P Geraghty, C J Mussap and E Burcher
    Molecular Pharmacology January 1992, 41 (1) 147-153;
  • You have access
    Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways.
    K W Crawford, E A Frey and T E Cote
    Molecular Pharmacology January 1992, 41 (1) 154-162;
  • You have access
    Carbachol-induced decrease in thyroid cell adenylyl cyclase activity is independent of calcium and phosphodiesterase activation.
    D Pasquali, C S Rani and W J Deery
    Molecular Pharmacology January 1992, 41 (1) 163-167;
  • You have access
    Regulation of GDP and GTP binding in cardiac sarcolemma by muscarinic receptor agonists.
    E Quist
    Molecular Pharmacology January 1992, 41 (1) 168-176;
  • You have access
    Guanylnucleotide specificity for muscarinic receptor inhibitory coupling to cardiac adenylate cyclase.
    E Quist, P Powell and R Vasan
    Molecular Pharmacology January 1992, 41 (1) 177-184;
  • You have access
    Molecular determinants of mu receptor recognition for the fentanyl class of compounds.
    C Cometta-Morini, P A Maguire and G H Loew
    Molecular Pharmacology January 1992, 41 (1) 185-196;
  • You have access
    Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
    H T Ho, K L Woods, J J Bronson, H De Boeck, J C Martin and M J Hitchcock
    Molecular Pharmacology January 1992, 41 (1) 197-202;
  • You have access
    Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds.
    Z Debyser, R Pauwels, K Andries, J Desmyter, Y Engelborghs, P A Janssen and E De Clercq
    Molecular Pharmacology January 1992, 41 (1) 203-208;
  • You have access
    Phase II metabolism of warfarin in primary culture of adult rat hepatocytes.
    R L Jansing, E S Chao and L S Kaminsky
    Molecular Pharmacology January 1992, 41 (1) 209-215;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 41, Issue 1
1 Jan 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics